Paw CBD Recognized With “Dog Hip & Joint Product Of The Year” Award From Pet Innovation
17 août 2023 08h00 HE
|
Pet Innovation Awards
LOS ANGELES, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
NextEvo Announces Free CBD for Parents Dealing With Back to School Stress and Anxiety on National CBD Day, Plus Giveaway for a Year Supply of CBD
10 août 2023 08h00 HE
|
NextEvo, Inc.
CONSHOHOCKEN, PA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – NextEvo Naturals (“NextEvo” or the “Company”), a premium supplement brand focused on revolutionizing the delivery of...
Boston Hemp Inc. Releases Hemp Derived THCa Diamonds Through Nationwide Distribution
08 août 2023 09h35 HE
|
Boston Hemp Inc.
BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via IBN - Boston Hemp Inc., a leading provider of premium hemp products, is proud to announce the nationwide release of its highly anticipated THCa...
Golden Triangle Ventures Announces the Launch of Sales on Its Le Pragma CBD Product Line
08 août 2023 08h30 HE
|
Golden Triangle Ventures, Inc.
LAS VEGAS, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) announces the launch of sales and provides an update on the progress...
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
28 juil. 2023 07h30 HE
|
Incannex Healthcare
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is...
Symple Seeds Opens Massive Fulfillment Center in South Florida to Service US Customers
26 juil. 2023 15h13 HE
|
Symple Seeds
MIAMI, July 26, 2023 (GLOBE NEWSWIRE) -- Symple Seeds, a cannabis seed shipping and logistics company with over a decade in the industry, is opening a new fulfillment center in South Florida. Now,...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
26 juil. 2023 07h30 HE
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
14 juil. 2023 07h55 HE
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
13 juil. 2023 08h00 HE
|
Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
BYND Cannasoft Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization
10 juil. 2023 08h30 HE
|
BYND Cannasoft Enterprises, Inc.
ASHKELON, Israel and VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today the...